EMA: HMPC Meeting Report published
Recommendation
13-15 May 2025
Vienna, Austria
Practical Approaches for USP General Chapter <1058> Compliance in the QC Laboratory
Register now for ECA's GMP Newsletter
On 27 November, 2017, the EMA's Committee on Herbal Medicinal Products (HMPC) published the HMPC meeting report about their meeting held from 20-21 November, 2017.
One of the meeting's key issues was the reflection paper on "Polycyclic Aromatic Hydrocarbons".
The HMPC decided for the comments received on reflection paper EMA/HMPC/300551/2015 to be published. HMPC approves the step-by-step approach suggested by the participants. The parties involved agreed to collect and share data.
Presently, the data available on contamination levels in herbal medicinal products is still very limited and therefore inadequate to serve as a basis for specific requirements and standardised controls. HMPC will also consider requirements from the food sector when determining limits for updating quality guidelines for herbal medicines in the future.
It was further decided by the HMPC that the Q&A document on herbal medicinal products is to be supplemented by a question on the difference between European monographs on herbal medicines and the individual "Product SmPCs".
For more deailed information please see the comprehensive "HMPC meeting report on European Union herbal monographs, guidelines and other activities" as well as the Herbal medicinal products: questions and answers.
Related GMP News
09.05.2025New ECA Guidance on Sampling and Sample Management
07.05.2025Public Consultation on ICH M13B Guideline on Bioequivalence launched in Switzerland
07.05.2025BioPhorum publishes Guidance for ICH Q2(R2) and Q14 Implementation
23.04.2025OTC Drug Production Ceased after FDA Warning Letter
23.04.2025EMA publishes Draft of ICH M13B Guideline on Bioequivalence
16.04.2025EMA publishes four new product-specific Bioequivalence Guidance